False Claims Act Insights cover art

All Episodes

False Claims Act Insights — 42 episodes

#
Title
1

Managed Care FCA Enforcement: Risk Adjustment, AI, Kickbacks, and More

2

Relators’ Attorneys’ Fees: Math, Limits, and How to Push Back

3

Healthcare Compensation and Referrals: Avoiding Compliance Pitfalls in Physician Deals

4

$1.6 Billion FCA Judgment on Appeal: What it Means for FCA Enforcement

5

Qui Tam Dismissals Are Spiking: What That Means for FCA Enforcement

6

DOJ Announces Record Number of Qui Tams and Qui Tam Dismissals

7

Rogue Employees: Vicarious Liability Under the False Claims Act

8

The Rise of State False Claims Act Enforcement

9

The Latest on Zafirov and the Future of Qui Tams

10

Understanding HIPAA Disclosures When Responding to CIDs in FCA Investigations

11

Recent Federal Executive Actions Place Anti-Discrimination Within the FCA’s Orbit

12

Be Careful What You Wish For: HHS-OIG Advisory Opinions

13

An FCA Perspective on Artificial Intelligence in the Healthcare Industry

14

Beyond Adversarialism: How to Steer FCA Investigations

15

The Mathematics of Nuclear FCA Verdicts

16

Bitter Pills: DOJ Targets Pharmacies for FCA Enforcement

17

Will Recent Leadership Changes Lead to FCA Enforcement Policy Changes?

18

How Payment Suspensions Can Impact FCA Litigation

19

Trump DOJ Sharpens Its Focus on Healthcare Fraud

20

DOJ’s Reliance on FCA to Pursue Covid-Related Fraud

21

Stranger Than Fiction? An FCA April Fools’ Day Episode

22

Emptying Our FCA Notebook: A Summary of Recent FCA-Related Developments

23

Can DE&I Initiatives Lead to Potential False Claims Act Liability?

24

Some FCA Whistles Are Louder Than Others

25

How Tariffs Can Increase Whistleblower Activity and Associated FCA Liability

26

Is DOJ Allowed to Share Privileged Documents with Whistleblowers in FCA Disputes?

27

Swamp Things: A Post-Election Look at DOJ’s False Claims Act Enforcement, Part II

28

Swamp Things: A Post-Election Look at DOJ’s False Claims Act Enforcement, Part I

29

How a Marine Fisheries Dispute Opened an FCA Can of Worms

30

Powerful, But Not All-Powerful: CIDs in FCA Litigation

31

Reality Checks: How to Approach Healthcare Transactions Without Triggering FCA Liability

32

Are the FCA’s Qui Tam Provisions Unconstitutional? One Federal Judge Says “Yes”

33

Are All Healthcare “Kickbacks” Subject to FCA Liability?

34

If Everything Matters, Nothing Does: Parsing Materiality in FCA Disputes

35

Assessing the Fallout from a Thermonuclear FCA Verdict

36

Eureka! Government Investigators Seek Out Research Misconduct

37

Physician, Refer Thyself: How Stark Law and FCA Intersect

38

The Art and Science of Corporate Compliance in Managing FCA Risk

39

Railroaded! How to Approach the Twin Tracks of Parallel Proceedings

40

Are We Done Here? The Unique Dynamics of FCA Settlements

41

Help! I Got a Civil Investigative Demand from DOJ. What Do I Do?

42

Think You Know Whistleblowers? Think Again.